Imatinib resistant BCR-ABL1 mutations at relapse in children with Ph(+)ALL: a Children’s Oncology Group (COG) study

Lignende værker

• BCR-ABL SH3-SH2 domain mutations in chronic myeloid leukemia patients on imatinib
  af: Sherbenou, Daniel W., et al.
  Udgivet: (2010)
• Imatinib spells BAD news for Bcr/abl-positive leukemias
  af: Kaufmann, Scott H.
  Udgivet: (2006)
• Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity
  af: Corbin, Amie S., et al.
  Udgivet: (2010)
• Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity
  af: Corbin, Amie S., et al.
  Udgivet: (2011)
• AHI-1 interacts with BCR-ABL and modulates BCR-ABL transforming activity and imatinib response of CML stem/progenitor cells
  af: Zhou, Liang L., et al.
  Udgivet: (2008)